{Reference Type}: Case Reports
{Title}: Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.
{Author}: Huang WK;Huang SC;Chen CM;Lin PH;Wu CE;Chuang CK;Yeh CN;
{Journal}: JCO Precis Oncol
{Volume}: 7
{Issue}: 0
{Year}: 01 2023
{Factor}: 5.479
{DOI}: 10.1200/PO.22.00528
{Abstract}: